Answers are grounded in this paper and cite their sources.
Comparative analysis demonstrates multimodal therapy improves survival in esophageal cancer, indicating its potential for personalized treatment.
Multimodal therapy improves survival over monotherapy in SCCE. CT + S and CT + RT offer comparable effectiveness, supporting their clinical interchangeability and broader use in individualized treatment planning.
No takes yet. Share an insight, caveat, or question.
Yin et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: